Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_assertion type Assertion NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_head.
- NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_assertion wasGeneratedBy ECO_0000203 NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_provenance.
- NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_assertion wasDerivedFrom befree-20140225 NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_provenance.
- NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_assertion SIO_000772 21293001 NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_provenance.
- NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_assertion evidence source_evidence_literature NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_provenance.
- NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_assertion description "[Treatment of human hepatocytes with resistin at levels observed in human obesity stimulated apoB secretion up to 10-fold, because of increased microsomal triglyceride transfer protein (MTP) activity and decreased expression/phosphorylation of proteins in the insulin signaling pathways (insulin receptor substrate-2, Akt, and extracellular signal-regulated kinase).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282164.RAUwAFiTdrbFpc9KhQylKGLK-use5JTX3nF8nC1Ujs8n8130_provenance.